HK78997A - Benzenedimethanol suitable for micronisation - Google Patents

Benzenedimethanol suitable for micronisation Download PDF

Info

Publication number
HK78997A
HK78997A HK78997A HK78997A HK78997A HK 78997 A HK78997 A HK 78997A HK 78997 A HK78997 A HK 78997A HK 78997 A HK78997 A HK 78997A HK 78997 A HK78997 A HK 78997A
Authority
HK
Hong Kong
Prior art keywords
process according
microcrystals
hot
organic
cold
Prior art date
Application number
HK78997A
Other languages
German (de)
English (en)
French (fr)
Inventor
Frederick Beach Steven
William Stuart Latham David
Gordon Roberts Tony
Brian Sidgwick Colin
Original Assignee
Glaxo Group Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Limited filed Critical Glaxo Group Limited
Publication of HK78997A publication Critical patent/HK78997A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/06—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
    • C07C217/08—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to an acyclic carbon atom
    • C07C217/10—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical containing six-membered aromatic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fats And Perfumes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
HK78997A 1990-11-29 1997-06-12 Benzenedimethanol suitable for micronisation HK78997A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB909026005A GB9026005D0 (en) 1990-11-29 1990-11-29 Drug material suitable for micronisation
PCT/GB1991/002108 WO1992009557A1 (en) 1990-11-29 1991-11-28 Benzenedimethanol suitable for micronisation

Publications (1)

Publication Number Publication Date
HK78997A true HK78997A (en) 1997-06-20

Family

ID=10686212

Family Applications (1)

Application Number Title Priority Date Filing Date
HK78997A HK78997A (en) 1990-11-29 1997-06-12 Benzenedimethanol suitable for micronisation

Country Status (27)

Country Link
US (1) US5380922A (cs)
EP (2) EP0639176B1 (cs)
JP (1) JP3375626B2 (cs)
KR (1) KR100192196B1 (cs)
AT (1) ATE144244T1 (cs)
AU (1) AU644505B2 (cs)
BG (1) BG61340B1 (cs)
CA (1) CA2099586C (cs)
CY (1) CY2009A (cs)
CZ (1) CZ282996B6 (cs)
DE (1) DE69122780T2 (cs)
DK (1) DK0639176T3 (cs)
ES (1) ES2093812T3 (cs)
FI (2) FI118155B (cs)
GB (1) GB9026005D0 (cs)
GR (1) GR3022088T3 (cs)
HK (1) HK78997A (cs)
HU (1) HU218205B (cs)
IE (1) IE914146A1 (cs)
OA (2) OA09861A (cs)
PL (2) PL169722B1 (cs)
RU (2) RU2197475C2 (cs)
SG (1) SG49741A1 (cs)
SK (1) SK281095B6 (cs)
TW (1) TW309425B (cs)
WO (1) WO1992009557A1 (cs)
ZA (1) ZA919401B (cs)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9026005D0 (en) * 1990-11-29 1991-01-16 Glaxo Group Ltd Drug material suitable for micronisation
WO1993016031A1 (en) * 1992-02-11 1993-08-19 Glaxo Group Limited Benzenedimethanol derivative suitable for micronisation
US6254882B1 (en) 1997-09-16 2001-07-03 Sepracor Inc. Methods and compositions for treating pulmonary disorders using optically pure (S)—salmeterol
JP2002541183A (ja) 1999-04-14 2002-12-03 グラクソ グループ リミテッド 医薬用エアゾール製剤
WO2002026239A1 (en) 2000-09-26 2002-04-04 Temple University Of The Commonwealth System Of Higher Education Analgesic and glucosamine compositions
EP2127641A1 (en) 2008-05-26 2009-12-02 Inke, S.A. Micronisable form of salmeterol xinafoate
KR101100614B1 (ko) 2010-09-20 2011-12-29 한국수력원자력 주식회사 농축폐액 건조물의 펠렛화 장치 및 방법과 이를 이용한 유리조성개발 방법
WO2016142582A1 (en) 2015-03-11 2016-09-15 Fermion Oy Process for the preparation of crystalline salmeterol and its xinafoate salt

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZW6584A1 (en) * 1983-04-18 1985-04-17 Glaxo Group Ltd Phenethanolamine derivatives
GB9026005D0 (en) * 1990-11-29 1991-01-16 Glaxo Group Ltd Drug material suitable for micronisation

Also Published As

Publication number Publication date
BG61340B1 (en) 1997-06-30
FI932422A0 (fi) 1993-05-27
KR100192196B1 (en) 1999-06-15
FI982081A0 (fi) 1998-09-28
CY2009A (en) 1998-02-20
US5380922A (en) 1995-01-10
EP0639176B1 (en) 1996-10-16
DK0639176T3 (da) 1996-12-23
TW309425B (cs) 1997-07-01
CZ101993A3 (en) 1994-01-19
CA2099586C (en) 2002-06-25
CZ282996B6 (cs) 1997-12-17
ZA919401B (en) 1992-07-29
OA10024A (en) 1996-10-14
SK54593A3 (en) 1993-10-06
DE69122780D1 (de) 1996-11-21
CA2099586A1 (en) 1992-05-30
OA09861A (en) 1994-08-15
EP0571669B1 (en) 1996-03-06
BG97767A (bg) 1994-12-02
EP0571669A1 (en) 1993-12-01
HUT64219A (en) 1993-12-28
FI118155B (fi) 2007-07-31
PL169722B1 (pl) 1996-08-30
GR3022088T3 (en) 1997-03-31
ES2093812T3 (es) 1997-01-01
EP0639176A1 (en) 1995-02-22
JPH06503082A (ja) 1994-04-07
SG49741A1 (en) 1998-06-15
GB9026005D0 (en) 1991-01-16
PL167976B1 (pl) 1995-12-30
FI118203B (fi) 2007-08-31
RU2197475C2 (ru) 2003-01-27
AU644505B2 (en) 1993-12-09
AU9040291A (en) 1992-06-25
HU9301568D0 (en) 1993-09-28
RU2116293C1 (ru) 1998-07-27
JP3375626B2 (ja) 2003-02-10
FI982081L (fi) 1998-09-28
DE69122780T2 (de) 1997-02-20
ATE144244T1 (de) 1996-11-15
HU218205B (hu) 2000-06-28
IE914146A1 (en) 1992-06-03
FI932422L (fi) 1993-05-27
SK281095B6 (sk) 2000-11-07
WO1992009557A1 (en) 1992-06-11

Similar Documents

Publication Publication Date Title
EP1005328B1 (en) Composition comprising finely divided, crystalline particles of budesonide
EP0639176B1 (en) Benzenedimethanol suitable for micronisation
WO2006091974A1 (en) Tadalafil having a large particle size and a process for preparation thereof
Keraliya et al. Formulation and Physical characterization of microcrystals for dissolution rate enhancement of Tolbutamide
AP323A (en) Drug material suitable for micronisation.
WO1993016031A1 (en) Benzenedimethanol derivative suitable for micronisation
IL101798A (en) 1-hydroxy-2-naphthalene carboxylate (hydroxynaphthoate) salt of 4-hydroxy- alpha1-[[[6-4-phenylbutoxy) hexyl] amino] methyl]-1,3-benzenedimethanol suitable for micronisation
NZ240788A (en) 1-hydroxy-2-naphthalene carboxylate salt of 4-hydroxy- alpha 1
US20040247689A1 (en) Process for preparing a pharmaceutical active ingredient with high specific surface area
SI9200252A (sl) Zdravilni material, primeren za mikronizacijo
EP2127641A1 (en) Micronisable form of salmeterol xinafoate
CN1056974C (zh) 适宜于微粒化的药物材料的制备方法
CN106880637B (zh) 一种环索奈德福莫特罗噻托溴铵复方干粉吸入剂组合物
EP0361659A2 (en) Pharmaceutical composition

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20091128